S.M.B. is a Belgian, independant, group of companies specialized in Research & Development and Manufacturing of pharmaceutical products.
The activities of S.M.B. involve new formulations and/or new chemical entities, clinical testing, registration and production of pharmaceutical products both in the US and EEC using both conventional and advanced drug delivery technologies.
Featured Content
SMB’s new website Welcome to the new version of SMB's website.
More information...Video presentation
Latest News
- Buprenorphin approval in Czech Republic and Scandinavia Buprenorphin from SMB has been recently approved in Scandinavia and ...
- PRAVAFENIX Marketing Authorization PRAVAFENIX ®, SMB’s fixed dose combination of Pravastatin and Fenofibrate ...
-
PRAVAFENIX APPROVAL
Laboratoires SMB obtained on 20 January 2011 a positive opinion ...